DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 55 filers reported holding DANAHER CORPORATION in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.4%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $49,565 | -12.7% | 200 | -15.6% | 0.02% | -6.2% |
Q2 2023 | $56,797 | -4.7% | 237 | 0.0% | 0.02% | -11.1% |
Q1 2023 | $59,613 | -5.0% | 237 | +0.4% | 0.02% | -10.0% |
Q4 2022 | $62,749 | +2.9% | 236 | 0.0% | 0.02% | 0.0% |
Q3 2022 | $61,000 | +1.7% | 236 | 0.0% | 0.02% | -4.8% |
Q2 2022 | $60,000 | -13.0% | 236 | 0.0% | 0.02% | +5.0% |
Q1 2022 | $69,000 | -11.5% | 236 | 0.0% | 0.02% | -16.7% |
Q4 2021 | $78,000 | +8.3% | 236 | 0.0% | 0.02% | 0.0% |
Q3 2021 | $72,000 | +14.3% | 236 | 0.0% | 0.02% | +14.3% |
Q2 2021 | $63,000 | +18.9% | 236 | 0.0% | 0.02% | +16.7% |
Q1 2021 | $53,000 | -1.9% | 236 | -2.5% | 0.02% | -5.3% |
Q4 2020 | $54,000 | +3.8% | 242 | 0.0% | 0.02% | -9.5% |
Q3 2020 | $52,000 | +20.9% | 242 | +0.4% | 0.02% | +10.5% |
Q2 2020 | $43,000 | +72.0% | 241 | +33.9% | 0.02% | +46.2% |
Q1 2020 | $25,000 | -10.7% | 180 | 0.0% | 0.01% | +18.2% |
Q4 2019 | $28,000 | – | 180 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARTHUR M. COHEN & ASSOCIATES, LLC | 232,593 | $60,115,000 | 16.52% |
Defender Capital, LLC. | 139,231 | $35,988,000 | 14.10% |
Third Point | 2,700,000 | $697,383,000 | 12.60% |
Riverstone Advisors, LLC | 62,416 | $16,121,000 | 10.38% |
Eos Focused Equity Management, L.P. | 32,304 | $8,344,000 | 9.87% |
Alphinity Investment Management Pty Ltd | 1,185,235 | $306,134,000 | 9.81% |
AGF Investments America Inc. | 88,205 | $22,782,000 | 8.41% |
Front Street Capital Management, Inc. | 117,802 | $30,427,000 | 7.70% |
CORTLAND ASSOCIATES INC/MO | 164,142 | $42,396,000 | 7.55% |
THAMES CAPITAL MANAGEMENT LLC | 57,156 | $14,763,000 | 7.33% |